Simplus, an Infosys company, is pleased to announce a collaboration with Salesforce for a vaccine management cloud solution built on the Salesforce Platform in support of Salesforce Work.com for Vaccines as the COVID-19 pandemic continues. Combining Simplus’ resources, capabilities, and Salesforce consulting and product expertise, the companies have created an end-to-end vaccine management solution to help support the federal government’s mandate for states to be ready to distribute a coronavirus vaccine.
Infosys vaccine management solution built on the Salesforce Platform covers a broad spectrum of vaccine management, including campaign management, citizen registration, prioritization, provider enrollment, supply chain visibility, forecasting, vaccine administration, wellness surveys, and adverse event monitoring. The solution is integrated with Salesforce Health Cloud that can help support compliance with applicable laws, such as HIPAA. Within this solution are two communities: one for residents and one for providers. The resident community is the one-stop-shop for individuals to find information, register with state and local governments, and schedule vaccine appointments. The provider community is the central hub for providers. Providers may, for example, apply to become a COVID-19 vaccine provider, manage appointments, maintain inventory, log vaccine administration details and document adverse effects.
Infosys vaccine management solution also utilizes other Salesforce products and solutions. Marketing Cloud leverages resident and provider data from Health Cloud to manage initial outreach, advocacy to resident populations, and follow-up communication concerning scheduling, adverse reactions and more. With MuleSoft, public health stakeholders can get a comprehensive view of their full vaccination efforts, on state and local levels, by securely and reliably integrating both their data from inside Salesforce and external data across EMR/EHRs, state-specific IISs, and CDC portals. Tableau can then be used to easily access and analyze that data through interactive visualizations to track and report population health outcomes and vaccination rates.
“As we work toward a global solution during the pandemic, the importance of a robust vaccine management solution cannot be overstated,” said Ryan Westwood, CEO of Simplus. “We are thrilled to bring life-changing solutions to protect our communities.”
Another benefit is the innovation team’s agile approach considering the parameters of the disease management are not yet known. Variables such as dosage frequency and vulnerable populations in geographies can be considered alongside other variables such as testing strategy and asymptomatic transmission. Vaccine management is tightly coupled with an effective containment strategy. Being able to act in concert with a widespread testing and containment strategy will be instrumental to the solution realizing its full potential.
“Infosys’ vaccine management solution combines the power of Health Cloud, Marketing Cloud, MuleSoft and Tableau,” said Eric Paternoster, CEO of Infosys Public Services. “We bring a holistic solution that can meet the demands of rigorous and expansive vaccine management programs. We have also architected the solution in modular fashion to complement existing systems that may already be in place. In this way, we are delivering the fastest time-to-value as well as acting in the interests of public good.”
“We are excited about Infosys’ vaccine management solution built on the Salesforce Platform,” said Tyler Prince, EVP of Partners and Industries, Salesforce. “Our partners are a key growth driver of the Salesforce economy, as they extend the functionality of our platform and help customers implement our technology. This solution exemplifies the impact of partner innovation combined with Salesforce products meeting an urgent community need.”
Simplus intends to integrate the vaccine management solution with testing and contact tracing to complete an overarching containment strategy for the public sector. The widespread testing strategy and preexisting public health initiatives will be instrumental to the solution realizing its full potential.
Salesforce, Work.com, Health Cloud, Marketing Cloud, Tableau, Mulesoft and others are trademarks of Salesforce.com, Inc.
We drive results that matter for the modern enterprise by accelerating strategic, industry-focused digital transformation in the Salesforce ecosystem. Our services include program strategy, platform implementation, organizational change management, data and systems integration, solution accelerators, and managed services. We offer end-to-end, industry-leading solutions to drive an innovative customer experience, operational efficiency, and overall profitable growth by combining best-in-class functional capabilities and technology automation with a user enablement focus. Visit simplus.com, email email@example.com, or call 833.SIMPLUS for more information.
Infosys is a global leader in next-generation digital services and consulting. We enable clients in 46 countries to navigate their digital transformation. With nearly four decades of experience in managing the systems and workings of global enterprises, we expertly steer our clients through their digital journey. We do it by enabling the enterprise with an AI-powered core that helps prioritize the execution of change. We also empower the business with agile digital at scale to deliver unprecedented levels of performance and customer delight. Our always-on learning agenda drives their continuous improvement through building and transferring digital skills, expertise, and ideas from our innovation ecosystem.
Visit www.infosys.com to see how Infosys (NYSE: INFY) can help your enterprise navigate your next.
Certain statements in this release concerning our future growth prospects, financial expectations and plans for navigating the COVID-19 impact on our employees, clients and stakeholders are forward-looking statements intended to qualify for the ‘safe harbor’ under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding COVID-19 and the effects of government and other measures seeking to contain its spread, risks related to an economic downturn or recession in India, the United States and other countries around the world, changes in political, business, and economic conditions, fluctuations in earnings, fluctuations in foreign exchange rates, our ability to manage growth, intense competition in IT services including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, industry segment concentration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks or system failures, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which Infosys has made strategic investments, withdrawal or expiration of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property and general economic conditions affecting our industry and the outcome of pending litigation and government investigation. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2020. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company’s filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.